Loading...
Verastem, Inc.
VSTM•NASDAQ
HealthcareBiotechnology
$6.42
$0.24(3.88%)
Verastem, Inc. (VSTM) Financial Performance & Statements
Review Verastem, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-24.84%
↓ 24.84%
Net Income Growth
-49.53%
↓ 49.53%
Operating Cash Flow Growth
-21.18%
↓ 21.18%
Operating Margin
-546129.17%
↓ 546129.17%
Gross Margin
25.00%
↑ 25.00%
Net Profit Margin
-620320.83%
↓ 620320.83%
ROE
5806.44%
↑ 5806.44%
ROIC
-136.42%
↓ 136.42%
Verastem, Inc. (VSTM) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Verastem, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $10.00M | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $6000.00 | $6000.00 |
| Gross Profit | $0.00 | $0.00 | $9.99M | -$6000.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $1.00 | |
| R&D Expenses | $20.81M | $24.75M | $18.06M | $17.71M |
| SG&A Expenses | $10.78M | $12.28M | $10.21M | $10.35M |
| Operating Expenses | $31.59M | $37.03M | $28.27M | $28.05M |
| Total Costs & Expenses | $31.59M | $37.03M | $28.28M | $28.06M |
| Interest Income | $968000.00 | $831000.00 | $983000.00 | $1.37M |
| Interest Expense | $1.15M | $1.15M | $1.14M | $1.13M |
| Depreciation & Amortization | $7000.00 | $7000.00 | $6000.00 | $6000.00 |
| EBITDA | -$63.21M | -$22.81M | -$7.11M | -$32.73M |
| EBITDA Ratio | -$0.71 | |||
| Operating Income | -$31.59M | -$37.03M | -$18.28M | -$28.06M |
| Operating Income Ratio | -$1.83 | |||
| Other Income/Expenses (Net) | -$32.78M | $13.06M | $10.02M | -$5.80M |
| Income Before Tax | -$64.37M | -$23.97M | -$8.26M | -$33.86M |
| Income Before Tax Ratio | -$0.83 | |||
| Income Tax Expense | $185000.00 | $0.00 | $0.00 | -$37276.00 |
| Net Income | -$64.55M | -$23.97M | -$8.26M | -$33.86M |
| Net Income Ratio | -$0.83 | |||
| EPS | -$1.33 | -$0.60 | -$0.31 | -$1.26 |
| Diluted EPS | -$1.33 | -$0.60 | -$0.31 | -$1.26 |
| Weighted Avg Shares Outstanding | $48.71M | $40.26M | $26.86M | $26.83M |
| Weighted Avg Shares Outstanding (Diluted) | $48.71M | $40.26M | $26.86M | $26.83M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan